| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9810 | 
      | Human Intestinal Absorption | HIA+ | 0.9937 | 
      | Caco-2 Permeability | Caco2+ | 0.7897 | 
      | P-glycoprotein Substrate | Substrate | 0.7069 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.6999 | 
                                                     | Non-inhibitor | 0.9594 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.6428 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.5341 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8378 | 
      | CYP450 2D6 Substrate | Substrate | 0.5212 | 
      | CYP450 3A4 Substrate | Substrate | 0.6502 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9107 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9081 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.8931 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.8993 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7379 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8129 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6267 | 
                                                                    | Non-inhibitor | 0.8853 | 
      | AMES Toxicity | AMES toxic | 0.7050 | 
      | Carcinogens | Non-carcinogens | 0.9428 | 
      | Fish Toxicity | High FHMT | 0.9735 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9329 | 
      | Honey Bee Toxicity | Low HBT | 0.6332 | 
      | Biodegradation | Ready biodegradable | 0.5468 | 
      | Acute Oral Toxicity | III | 0.7503 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5416 |